DOT Drug Test

A federally regulated urine drug test following strict 49 CFR Part 40 procedures, required for safety-sensitive employees in DOT-regulated industries.

Key Facts

  • Standard 5-panel: marijuana, cocaine, amphetamines, opioids, PCP
  • Oral fluid testing approved by DOT since June 2023
  • MRO reviews all non-negative results before reporting
  • Chain of custody required from collection to reporting
  • Pre-employment test must be negative before safety-sensitive work

DOT drug testing follows precise chain-of-custody procedures mandated by 49 CFR Part 40. The standard DOT panel tests for five drug classes: marijuana (THC), cocaine, amphetamines/methamphetamines, opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, 6-AM/heroin), and PCP. Testing is required pre-employment, randomly, post-accident, upon reasonable suspicion, return-to-duty, and for follow-up. All specimens must be analyzed by SAMHSA-certified laboratories and results reviewed by a Medical Review Officer (MRO).

Drug Testing Methods Compared

Side-by-side comparison of common workplace drug testing approaches.

TypePanel SizeDetection WindowSpecimenDOT Approved
DOT 5-Panel5 substances1–3 daysUrine or oral fluidYes
Non-DOT Panel5–17+ substances1–3 daysUrineN/A
Hair Follicle5–17+ substancesUp to 90 daysHairNo
Oral Fluid5–12+ substances24–48 hoursSalivaYes (since 2023)

Simplify Your Compliance

BlueHive manages occupational health services so you can focus on your workforce.

Chat with Bea